New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia.
about
Chronic immune activation and inflammation as the cause of malignancyGene expression signature of benign prostatic hyperplasia revealed by cDNA microarray analysisEstrogen-initiated transformation of prostate epithelium derived from normal human prostate stem-progenitor cellsMonitoring mouse prostate development by profiling and imaging mass spectrometry.Mouse models of prostate cancer.Symptomatic and asymptomatic benign prostatic hyperplasia: molecular differentiation by using microarrays.Tomato sauce supplementation and prostate cancer: lycopene accumulation and modulation of biomarkers of carcinogenesis.Lower urinary tract symptoms and diet quality: findings from the 2000-2001 National Health and Nutrition Examination Survey.Estrogen-induced generation of reactive oxygen and nitrogen species, gene damage, and estrogen-dependent cancers.LILRA3 is associated with benign prostatic hyperplasia risk in a Chinese Population.Human prostate cancer heterotransplants: a review on this experimental modelInflammation and prostate cancer.Human benign prostatic hyperplasia heterotransplants as an experimental model.Relationship of oestrogen receptor alpha gene polymorphisms with risk for benign prostatic hyperplasia and prostate cancer in Chinese men.The role of inflammatory mediators in the development of prostatic hyperplasia and prostate cancerLower urinary tract symptoms, benign prostatic hyperplasia/benign prostatic enlargement and erectile dysfunction: are these conditions related to vascular dysfunction?Association of symptomatic benign prostatic hyperplasia and prostate cancer: results from the prostate cancer prevention trial.Going viral? Linking the etiology of human prostate cancer to the PCA3 long noncoding RNA and oncogenic viruses.Development of quantitative detection assays for CYR61 as a new marker for benign prostatic hyperplasia.Multi-parametric MR imaging of transition zone prostate cancer: Imaging features, detection and staging.MD-miniRNA could be a more accurate biomarker for prostate cancer screening compared with serum prostate-specific antigen level.Prostatic ischemia induces ventral prostatic hyperplasia in the SHR; possible mechanism of development of BPH.Chronic bacterial inflammation induces prostatic intraepithelial neoplasia in mouse prostate.Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis.Hypermethylation of the human glutathione S-transferase-pi gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: a detailed study using laser-capturGSTA1 expression in normal, preneoplastic, and neoplastic human prostate tissue.Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention.Canine prostate carcinomas express markers of urothelial and prostatic differentiation.Prevalence and risk factors of lower urinary tract symptoms in Chinese adult men: a multicentre cross-sectional study.Gene expression profiling of the human prostate zones.Evolution: Back to the future to understand and control prostate cancer.Androgen action in prostate function and disease.
P2860
Q24648532-F8AD42B4-B545-4CD6-8ABE-5B96971C8C9EQ28215493-81EA818C-E095-467C-9FCF-2E28EDB8B453Q30426649-5DEE5E20-715C-4630-8E4B-1AD8C32BA5ACQ30835906-4B8C2671-FB7A-4133-BEF7-F50149BD01C0Q33739296-A4AA2156-57DB-413A-8224-FBE1A3A13D04Q34064723-C932D588-6C8C-4C20-90A4-DB28C20C182FQ34528806-FD17399A-7581-4199-A58E-F424C3EF8A55Q36590762-F7B7DF50-539F-4D72-990E-A0D4E97733F7Q36874434-436BB946-D77F-4DA9-922C-3FAEA1254276Q36913505-93E4773B-B704-449B-99FD-33F5D58CF0F2Q37084692-0ACB73D1-6C47-4F36-A781-5C4A9C08BA65Q37298650-5075B3B1-08A3-486F-B35D-B1C932FAC220Q37641037-B28B6BB9-5E8C-4A9C-ACEB-331783224E88Q37737283-DDC2214C-DC3A-4C80-8F74-3AC9BB2F5D1DQ38176621-7C7A20FC-432E-4F94-9562-8A45227E898CQ38220350-4BBB581F-14DD-4F4C-99DE-77C1055368C5Q39981630-5AA660D9-FC40-49BB-884C-E467219CB863Q40104911-63253E2B-9C5D-4C3A-A4BC-8A6B11FB5975Q40601417-41933AD2-160B-438E-8DC7-9A1859BC1B7EQ41138148-9294F7F2-156C-4C28-8530-2B782B14B4FDQ41626983-2022A71F-EDB8-48B5-8FFE-5A95F3B0C683Q41883463-CDAD2961-E76F-4C47-9B9F-1BBBD7E41A0EQ41899298-1755F1C4-E4E2-4C18-B206-CC15FD0AAD9CQ41899984-7CD80C8E-B79C-48EC-9091-9BAFEF565F79Q42047685-DC000B5A-3C1A-461F-B261-B1D9C2E726AEQ43732915-5508F97D-C86D-445D-BA78-DEFEEC39874AQ43829953-F41BECA9-1D7B-4D92-B55A-80C180BE1F54Q44797141-894CA4E9-7617-4408-9C18-FCEF814F5B52Q47710406-9CE9F8CA-82B7-41DD-A6EF-21217EB662B7Q54580971-9B2CB20F-C79E-4674-9599-5DB81C1AA328Q55209354-46BF2D24-0AFF-41F0-A16A-3986FCE2211AQ55251761-5C31731E-BA9E-4EEE-82BA-6D8B15CC055F
P2860
New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia.
@ast
New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia.
@en
New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia.
@nl
type
label
New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia.
@ast
New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia.
@en
New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia.
@nl
prefLabel
New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia.
@ast
New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia.
@en
New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia.
@nl
P2093
P1433
P1476
New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia.
@en
P2093
P304
29-39; discussion 39-42
P356
10.1016/S0090-4295(98)00536-6
P407
P433
3 Suppl 3a
P577
1999-03-01T00:00:00Z